ADAM17 and cancer: RA also down-regulated the expression level of ADAM17, EGFR, p-AKT and p-GSK3β in melanoma cells, suggesting that RA had the anti-cancer potential for melanoma treatment, and the underlying mechanism may be related to inhibiting the activation of ADAM17/EGFR/AKT/GSK3β axis.